Long-term NACT may lead to depletion extravasation of CD8+T cells in GC-TLS, and combined immunotherapy maintains the efficacy of GC-TLS by reshaping the spatial distribution of CD8+T cells. This evidence concerns the gene CD8A and Tumor Lysis Syndrome.